Sort   by:  
 Page size 
UnknownTrauma in CT: The Role of Severe Injury on Satisfaction of Search Revised.
Not available
S-EPMC4975624 | biostudies-literature
UnknownCollagen VI deficiency reduces muscle pathology, but does not improve muscle function, in the γ-sarcoglycan-null mouse.
Not available
S-EPMC4787905 | biostudies-literature
TranscriptomicsSubstitutions in the KRas oncogene determine protein behavior: Implications for signaling and clinical outcome.
Mutant KRAS (mut-KRAS) is present in 30% of all human cancers and plays a critical role in cancer cell growth and resistance to therapy. There is evidence from colon cancer that mut-KRAS is a poor prognostic factor and negative predictor of patient response to molecularly targeted therapy. However,...
ORGANISM(S): Homo sapiens 
2012-01-01 | E-GEOD-27389 | biostudies-arrayexpress
TranscriptomicsAn epithelial-mesenchymal transition (EMT) gene signature predicts resistance to erlotinib and PI3K pathway inhibitors and identifies Axl as a novel EMT marker in non-small cell lung cancer.
Epithelial/mesenchymal transition (EMT) is associated with loss of cell adhesion molecules, such as E-cadherin, and increased invasion, migration, and proliferation in epithelial cancers. In non-small cell lung cancer (NSCLC), EMT is associated with greater resistance to EGFR inhibitors. However, it...
ORGANISM(S): Homo sapiens 
2012-10-25 | E-GEOD-33072 | biostudies-arrayexpress
UnknownFinal efficacy and biomarker analysis of the sorafenib arm of the BATTLE (Biomarker-Integrated Approaches of Targeted Therapy for Lung Cancer Elimination) trial
Not available
ORGANISM(S): Homo sapiens 
S-ECPF-GEOD-31428 | biostudies-other
ProteomicsComparison of proteins in secretory/excretory products of the salmon louse, Lepeophtheirus salmonis.
Comparative Proteomics of the Secretory/Excretory products (SEPs) of 2 life stages L.salmonisusing LC-ESI-MS/MS.
ORGANISM(S): Lepeophtheirus salmonis 
2018-10-19 | PXD009391 | Pride
Esi-lc-ms/ms E/s Excretory/secretory products Ion-trap L. salmonis 
TranscriptomicsFinal efficacy and biomarker analysis of the sorafenib arm of the BATTLE (Biomarker-Integrated Approaches of Targeted Therapy for Lung Cancer Elimination) trial
Purpose: To determine the 8-week disease control rate (DCR) of sorafenib monotherapy in patients with advanced non-small-cell lung cancer (NSCLC) in the BATTLE trial. Methods: Patients with pre-treated NSCLC consented to baseline biopsies for pre-specified biomarkers assessment and biomarker discove...
ORGANISM(S): Homo sapiens 
2014-06-01 | E-GEOD-31428 | biostudies-arrayexpress
UnknownSubstitutions in the KRas oncogene determine protein behavior: Implications for signaling and clinical outcome
Not available
ORGANISM(S): Homo sapiens 
S-ECPF-GEOD-27389 | biostudies-other
ProteomicsMtruncatula - Stem, iBAQ (Marxetal,natbiotechnol2016)
abundance based on iBAQ, Interaction consistency score: 14.8, Coverage: 27
ORGANISM(S): 3880 
2016-00-00 | 2164794630 | PAXDB
ProteomicsMtruncatula - Root, iBAQ (Marxetal,natbiotechnol2016)
abundance based on iBAQ, Interaction consistency score: 13.0, Coverage: 29
ORGANISM(S): 3880 
2016-00-00 | 3047189613 | PAXDB
Sort   by:  
 Page size